In recent years, research on emotion recognition has become more and more popular, but there are few studies on emotion recognition based on cerebral blood oxygen signals. Since the electroencephalogram (EEG) is easily disturbed by eye movement and the portability is not high, this study uses a more comfortable and convenient functional near-infrared spectroscopy (fNIRS) system to record brain signals from participants while watching three different types of video clips. During the experiment, the changes in cerebral blood oxygen concentration in the 8 channels of the prefrontal cortex of the brain were collected and analyzed. We processed and divided the collected cerebral blood oxygen data, and used multiple classifiers to realize the identification of the three emotional states of joy, neutrality, and sadness. Since the classification accuracy of the convolutional neural network (CNN) in this research is not significantly superior to that of the XGBoost algorithm, this paper proposes a CNN-Transformer network based on the characteristics of time series data to improve the classification accuracy of ternary emotions. The network first uses convolution operations to extract channel features from multi-channel time series, then the features and the output information of the fully connected layer are input to the Transformer netork structure, and its multi-head attention mechanism is used to focus on different channel domain information, which has better spatiality. The experimental results show that the CNN-Transformer network can achieve 86.7% classification accuracy for ternary emotions, which is about 5% higher than the accuracy of CNN, and this provides some help for other research in the field of emotion recognition based on time series data such as fNIRS.

Within the fields of infectious disease diagnostics, microfluidic-based integrated technology systems have become a vital technology in enhancing the rapidity, accuracy, and portability of pathogen detection. These systems synergize microfluidic techniques with advanced molecular biology methods, including reverse transcription polymerase chain reaction (RT-PCR), loop-mediated isothermal amplification (LAMP), and clustered regularly interspaced short palindromic repeats (CRISPR), have been successfully used to identify a diverse array of pathogens, including COVID-19, Ebola, Zika, and dengue fever. This review outlines the advances in pathogen detection, attributing them to the integration of microfluidic technology with traditional molecular biology methods and smartphone- and paper-based diagnostic assays. The cutting-edge diagnostic technologies are of critical importance for disease prevention and epidemic surveillance. Looking ahead, research is expected to focus on increasing detection sensitivity, streamlining testing processes, reducing costs, and enhancing the capability for remote data sharing. These improvements aim to achieve broader coverage and quicker response mechanisms, thereby constructing a more robust defense for global public health security.

Pathogenic microorganisms play a crucial role in the global disease burden due to their ability to cause various diseases and spread through multiple transmission routes. Immunity tests identify antigens related to these pathogens, thereby confirming past infections and monitoring the host’s immune response. Traditional pathogen detection methods, including enzyme-linked immunosorbent assays (ELISAs) and chemiluminescent immunoassays (CLIAs), are often labor-intensive, slow, and reliant on sophisticated equipment and skilled personnel, which can be limiting in resource-poor settings. In contrast, the development of microfluidic technologies presents a promising alternative, offering automation, miniaturization, and cost efficiency. These advanced methods are poised to replace traditional assays by streamlining processes and enabling rapid, high-throughput immunity testing for pathogens. This review highlights the latest advancements in microfluidic systems designed for rapid and high-throughput immunity testing, incorporating immunosensors, single molecule arrays (Simoas), a lateral flow assay (LFA), and smartphone integration. It focuses on key pathogenic microorganisms such as SARS-CoV-2, influenza, and the ZIKA virus (ZIKV). Additionally, the review discusses the challenges, commercialization prospects, and future directions to advance microfluidic systems for infectious disease detection.